Former Pfizer executives not involved in Starboard campaign against drugmaker By Reuters

(Reuters) – Pfizer Former (NYSE: ) CEO and Chairman Ian Read and former CFO Frank D’Amelio said in a statement that they will not be involved with activist investor Starboard Value, which wants the US drug giant to make changes to turn its performance. .

“We fully support Pfizer Chairman and CEO Albert Bourla, senior management and the board of directors and are confident that over time they will deliver shareholder value,” executives said in a statement Wednesday, which was issued by Guggenheim Partners, an advisor to Pfizer.

Pfizer and Starboard did not immediately respond to a Reuters request for comment.

Read, who served as CEO until Albert Bourla took over in 2019, and D’Amelio, who served as CFO until 2021, both expressed interest in helping Starboard Value after it acquired a stake in about $1 billion at Pfizer, familiar sources. with the matter said Reuters on Sunday.